Novavax Payables Turnover from 2010 to 2024

NVAX Stock  USD 8.47  0.43  5.35%   
Novavax Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover is likely to outpace its year average in 2024. Payables Turnover is a liquidity ratio that shows how quickly Novavax pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
2.59232335
Current Value
4.73
Quarterly Volatility
16.76430388
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novavax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novavax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.3 M, Interest Expense of 15.1 M or Selling General Administrative of 499.1 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0066 or Days Sales Outstanding of 82.31. Novavax financial statements analysis is a perfect complement when working with Novavax Valuation or Volatility modules.
  
Check out the analysis of Novavax Correlation against competitors.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Latest Novavax's Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of Novavax over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Novavax's Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novavax's overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Pretty Stable
   Payables Turnover   
       Timeline  

Novavax Payables Turnover Regression Statistics

Arithmetic Mean13.81
Coefficient Of Variation121.35
Mean Deviation13.86
Median4.55
Standard Deviation16.76
Sample Variance281.04
Range42.6038
R-Value0.11
Mean Square Error298.90
R-Squared0.01
Significance0.69
Slope0.42
Total Sum of Squares3,935

Novavax Payables Turnover History

2024 4.73
2023 2.59
2022 4.17
2021 0.0997
2020 13.75
2017 39.12
2016 41.85

About Novavax Financial Statements

Novavax investors use historical fundamental indicators, such as Novavax's Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novavax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Payables Turnover 2.59  4.73 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.